Chronic treatment with human recombinant erythropoietin increases hematocrit and improves water maze performance in mice
- 31 January 1996
- journal article
- Published by Elsevier in Physiology & Behavior
- Vol. 59 (1) , 153-156
- https://doi.org/10.1016/0031-9384(95)02046-2
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Milacemide treatment in mice enhances acquisiton of a Morris-type water maze taskPharmacology Biochemistry and Behavior, 1994
- Altered Brain Metabolism of Iron as a Cause of Neurodegenerative Diseases?Journal of Neurochemistry, 1994
- Peptide hormones and sport: Misuse and detectionBritish Medical Bulletin, 1992
- Subjective Quality of Life Assessment in Hemodialysis Patients at Different Levels of Hemoglobin following Use of Recombinant Human ErythropoietinAmerican Journal of Nephrology, 1992
- Recombinant erythropoietin improves cognitive function in chronic haemodialysis patientsNephrology Dialysis Transplantation, 1992
- Iron and oxygen radicals in brainAnnals of Neurology, 1992
- rHuEPO treatment improves brain and cognitive function of anemic dialysis patientsKidney International, 1991
- The Hypoxic Stress on Erythrocytes Associated with Superoxide FormationFree Radical Research Communications, 1991
- Age population distribution of erythrocytes in young and old healthy donorsExperimental Gerontology, 1990
- Purification of human erythropoietin.Journal of Biological Chemistry, 1977